Follow us:
  1. Home
  2. News
  3. Recalls

Pendopharm recalls Axid

The medication is contaminated with a probable cancer-causer

Photo
Photo source: CVS
The Pendopharm Division of Pharmascience is recalling two lots of Axid (nizatidine) from the Canadian market.

The product, used to treat ulcers in the stomach and intestine, as well as heartburn, is contaminated with N-nitrosodimethylamine (NDMA), a probable cancer-causer.

The NDMA levels in the two lots being recalled are not higher than acceptable limits at this time, but could increase with time.

The following product, sold throughout Canada, is being recalled:

CompanyProduct Name/Active Pharmaceutical Ingredient (API)DINStrengthLotExpiry
Pendopharm Division of Pharmascience Inc.AXID CAPS 10000778338150mg61692731-08-2020
61708831-08-2020
 

What to do

Patients taking the recalled product should not stop taking it unless they have spoken to their health care provider and obtained alternative treatment.

Cosnsumers with questions may contact Pendopharm toll-free at (888) 550-6060 or by email at med.info@pharmascience.com.